pioglitazone has been researched along with Diabetes, Gestational in 4 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Diabetes, Gestational: Diabetes mellitus induced by PREGNANCY but resolved at the end of pregnancy. It does not include previously diagnosed diabetics who become pregnant (PREGNANCY IN DIABETICS). Gestational diabetes usually develops in late pregnancy when insulin antagonistic hormones peaks leading to INSULIN RESISTANCE; GLUCOSE INTOLERANCE; and HYPERGLYCEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The Pioglitazone In Prevention Of Diabetes (PIPOD) study was conducted to evaluate beta-cell function, insulin resistance, and the incidence of diabetes during treatment with pioglitazone in Hispanic women with prior gestational diabetes who had completed participation in the Troglitazone In Prevention Of Diabetes (TRIPOD) study." | 5.12 | Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes. ( Buchanan, TA; Goico, J; Kawakubo, M; Kjos, SL; Marroquin, A; Ochoa, C; Peters, RK; Xiang, AH, 2006) |
| "Women with a history of gestational diabetes are at high risk for developing type 2 diabetes mellitus." | 2.55 | Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review. ( Grajower, MM; Kasher-Meron, M, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kasher-Meron, M | 1 |
| Grajower, MM | 1 |
| Xiang, AH | 2 |
| Peters, RK | 2 |
| Kjos, SL | 2 |
| Marroquin, A | 2 |
| Goico, J | 2 |
| Ochoa, C | 2 |
| Kawakubo, M | 2 |
| Buchanan, TA | 2 |
| Hodis, HN | 1 |
| Liu, CR | 1 |
| Liu, CH | 1 |
| Goldenberg, N | 1 |
| Glueck, C | 1 |
2 reviews available for pioglitazone and Diabetes, Gestational
| Article | Year |
|---|---|
Preventing progression from gestational diabetes mellitus to diabetes: A thought-filled review.
Topics: Adult; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease Progression; Female; Humans; Hypogl | 2017 |
Medical therapy in women with polycystic ovarian syndrome before and during pregnancy and lactation.
Topics: Adult; Clomiphene; Diabetes, Gestational; Drug Therapy, Combination; Female; Fertility Agents, Femal | 2008 |
2 trials available for pioglitazone and Diabetes, Gestational
| Article | Year |
|---|---|
Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetes.
Topics: Adult; Body Weight; Diabetes Mellitus, Type 2; Diabetes, Gestational; Female; Hispanic or Latino; Hu | 2006 |
Effect of pioglitazone on progression of subclinical atherosclerosis in non-diabetic premenopausal Hispanic women with prior gestational diabetes.
Topics: Adult; Carotid Artery Diseases; Chromans; Diabetes Mellitus, Type 2; Diabetes, Gestational; Disease | 2008 |